GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Ceftaroline (Teflaro)

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Teflaro - labeled renal guidance

Product / population
Ceftaroline fosamil (Teflaro), adult IV infusion
Renal method
Cockcroft-Gault CrCl, mL/min
Source revision
DailyMed SPL version 43, posted Nov 17, 2025
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Teflaro - product and source limitations

The pediatric table uses a different renal metric. Confirm the patient's age, indication and infusion instructions.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Teflaro - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Ceftaroline fosamil (Teflaro), adult IV infusion

Renal method: Cockcroft-Gault CrCl, mL/min
Source date: DailyMed SPL version 43, posted Nov 17, 2025
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 2, adult renal impairment dosing table

Limits that apply to these rows

The pediatric table uses a different renal metric. Confirm the patient's age, indication and infusion instructions.

Adult indication-specific ceftaroline renal regimens
Cockcroft-Gault CrCl (mL/min)Adult IV dose
>30 to 50400 mg every 12 hours
15 to 30300 mg every 12 hours
<15, including ESRD200 mg every 12 hours; after HD on dialysis days
Read the retained text before reformatting

Adult IV ceftaroline doses every 12 hours are 400 mg at CrCl above 30 through 50, 300 mg at 15 through 30, and 200 mg below 15 mL/min, including ESRD on HD. Administer after HD on dialysis days. The pediatric table uses a different renal metric. Confirm the patient's age, indication and infusion instructions.

RDM74-teflaro-official-1 · Source locator: Renal guidance: 2, adult renal impairment dosing table

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ecde48b-75a2-4beb-9999-369f3f61bb8a
Retrieved
2026-11-07
Renal-function method
Cockcroft-Gault CrCl, mL/min
Source date/version
DailyMed SPL version 43, posted Nov 17, 2025
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
3e2a602db6d6a0181fded404e6cc0d318e5f5284745a5f89da42d77aee0287cf

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ceftaroline&s1=RDM74-teflaro-official&h1=b259994bae0f4143a549f6fd1d044190bd4fad0f472a356ea3347485c1aea777

Top